newsfilter
← Latest News
GlobeNewswire·

Petros Pharmaceuticals, Inc. Engages Massachusetts General Hospital in a Sponsored Research Agreement for Tissue-Specific Oxygenation Sensor Technology

NEW YORK, April 26, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. ((Petros, NASDAQ:PTPI), a leading provider of therapeutics for men's health, today announces it has entered into a Sponsored Research Agreement (SRA) and an Option Agreement with